CLMTBasic Materials · Specialty ChemicalsThe 6 Wall Street analysts covering Calumet, Inc. hold a median 12-month price target of $47 — -18.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 15 Oct 2026 — inside the top quartile. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Calumet, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (99): The shares have been drifting up relative to others.
Value (16): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CLMT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −18.6% from it.
Of the 20 most recent actions, 6 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Sept 2026 | HC Wainwright & Co. | Maintains | Buy | $60 → $75 |
| 25 Aug 2026 | UBS | Maintains | Neutral | $26 → $47 |
| 25 Aug 2026 | UBS | Maintains | Neutral | — |
| 18 Aug 2026 | Goldman Sachs | Maintains | Neutral | $40 → $45 |
| 18 Aug 2026 | Goldman Sachs | Maintains | Neutral | — |
| 12 Aug 2026 | TD Cowen | Maintains | Hold | — |
| 12 Aug 2026 | TD Cowen | Maintains | Hold | $34 → $40 |
| 30 July 2026 | Goldman Sachs | Maintains | Neutral | $36 → $40 |
| 30 July 2026 | Goldman Sachs | Maintains | Neutral | — |
| 30 Mar 2026 | HC Wainwright & Co. | Maintains | Buy | $33 → $60 |
| 30 Mar 2026 | HC Wainwright & Co. | Maintains | Buy | — |
| 12 Mar 2026 | Goldman Sachs | Maintains | Buy | — |
| 30 Jan 2026 | Goldman Sachs | Maintains | Buy | — |
| 10 Nov 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 22 Oct 2025 | Goldman Sachs | Maintains | Buy | — |
| 12 Aug 2025 | UBS | Maintains | Neutral | — |
| 14 May 2025 | Wells Fargo | Maintains | Overweight | — |
| 13 May 2025 | B of A Securities | Initiates | Buy | — |
| 30 Apr 2025 | Goldman Sachs | Maintains | Buy | — |
| 9 Apr 2025 | Wells Fargo | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CLMT appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 16 Oct 2026, Calumet, Inc. returned +204.7% against +16.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 28% of US stocks
Cheaper than 66% of US stocks
Cheaper than 97% of US stocks
Cheaper than 2% of US stocks
Higher than 83% of US stocks
Higher than 71% of US stocks
Higher than 5% of US stocks
Higher than 28% of US stocks
Higher than 26% of US stocks
Higher than 57% of US stocks
Higher than 39% of US stocks
Higher than 92% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Calumet, Inc. has a market value of $5.1B and an enterprise value of $7.6B.
Revenue in the twelve months to 30 June 2026: $4.6B. The latest quarter grew 40.8% year on year.
Net income over the same four quarters: −$136.8M, a −3.0% net margin.
Diluted earnings per share, trailing twelve months: $−1.55.
Free cash flow in the twelve months to 30 June 2026: $73.5M.
Trailing P/E: 26.7×; forward P/E: 91.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 4.76%, paying out 0% of earnings.
Calumet, Inc. employs 1,540 people — $3.0M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Calumet, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Calumet announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp., have given notice to redeem $150 million of outstanding 9.75% Senior Notes due 2028.
Why it matters — The redemption notice concerns the issuer subsidiaries' outstanding debt and is relevant to CLMT watchers tracking the company's financing activity.
A Seeking Alpha article says Calumet Specialty Products could report Q3 EBITDA of $300–$325 million, citing strong crack spreads and operational improvements. The author lowered the rating from strong buy to buy, noting rich valuation, overbought technical indicators, and a planned Shreveport shutdown.
Why it matters — CLMT watchers may want to note the article’s expected quarterly EBITDA range alongside its valuation concerns and recommendation to wait until after earnings and the shutdown before adding shares.
Zacks Investment Research reported that CLMT was included on its Zacks Rank #1 (Strong Buy) momentum stocks list on October 13, 2026, alongside REPYY and TGT.
Why it matters — The item identifies CLMT as included in Zacks’ top-ranked momentum stocks list on that date.
Zacks Investment Research highlighted CLMT alongside ROKU, FET, FTI and SHEL after a screen found their efficiency ratios were above their industry averages.
Why it matters — The item identifies CLMT as one of the stocks meeting the screen's efficiency-ratio criterion.
Zacks Investment Research included CLMT among the Zacks Rank #1 (Strong Buy) momentum stocks listed for October 6, 2026, alongside CVX and SNDK.
Why it matters — The item notes that CLMT appeared on Zacks’ Strong Buy momentum-stock list for that date.
The 6 Wall Street analysts covering Calumet, Inc. have a median 12-month price target of $47, with estimates ranging from $40 to $75. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Calumet, Inc., 2 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Calumet, Inc. 80 out of 100 across roughly 4,600 US stocks as at 15 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Oct 2026, Calumet, Inc. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies -18.6% from the last close, and Ticker Nerd's factor model ranks Calumet, Inc. 80 out of 100 as at 15 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Calumet, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLMT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $40 to $75 over the next 12 months.
Calumet, Inc. returned +204.7% over the 12 months to 16 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Calumet, Inc. is a specialty products and renewable fuels company that manufactures, formulates, and markets a broad range of materials for industrial, commercial, and consumer applications.
The most recent item we track (PRNewsWire, 15 Oct 2026): "Calumet Issues Redemption Notice for $150 Million of 9.75% Senior Notes due 2028". Calumet announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp., have given notice to redeem $150 million of outstanding 9.75% Senior Notes due 2028.
Calumet, Inc. is a specialty products and renewable fuels company that manufactures, formulates, and markets a broad range of materials for industrial, commercial, and consumer applications. Calumet, Inc. operates through three main segments: Specialty Products and Solutions, Performance Brands, and Montana/Renewables. Its portfolio includes solvents, waxes, customized lubricating oils, white oils, esters, petrolatums, gels, and specialty fuels, along with branded products such as Royal Purple, Bel-Ray, and TruFuel. The company also produces renewable diesel, sustainable aviation fuel, renewable naphtha, and other refined products used across energy, transportation, infrastructure, and manufacturing markets. Headquartered in Indianapolis, Indiana, Calumet, Inc. serves wholesale distributors, retail chains, and industrial customers across North America and international markets.
CEO Mr. Louis Todd Borgmann · 1,540 employees · United States · https://www.calumet.com
